Evidence map›Paper›PMID 32548625›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2020

Hyperexcitability in Aging Is Lost in Alzheimer's: What Is All the Excitement About?

Colin T Lockwood, Charles J Duffy

Open access · bronzeAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Colin T LockwoodDepartments of Neurology and Brain and Cognitive Sciences, University of Rochester Medical Center, Rochester 14642, NY, USA.
Charles J DuffyDepartments of Neurology and Brain and Cognitive Sciences, University of Rochester Medical Center, Rochester 14642, NY, USA.
University of Rochester Medical Center · US

Funding

VISUAL SCIENCE RESEARCH CTR SUPPORTP30EY001319 · NEI · UNIVERSITY OF ROCHESTER · PI Susana Marcos · 1985 to 2026
$17.5M
The University of Rochester's Clinical and Translational Science InstituteTL1RR024135 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$3.7M
PERCEPTUAL MECHANISMS OF VISUOSPATIAL ORIENTATIONR01AG017596 · NIA · UNIVERSITY OF ROCHESTER · PI DUFFY, CHARLES J · 2000 to 2010
$3.2M
Integrating Neurophysiological Views of the Aging Visual SystemR01EY022062 · NEI · UNIVERSITY OF ROCHESTER · PI DUFFY, CHARLES J · 2012 to 2016
$2.5M
NCRR NIH HHS TL1 RR024135NEI NIH HHS P30 EY001319NEI NIH HHS R01 EY022062NIA NIH HHS R01 AG017596
6 · The paper itself

Abstract

Neuronal hyperexcitability has emerged as a potential biomarker of late-onset early-stage Alzheimer's disease (LEAD). We hypothesize that the aging-related posterior cortical hyperexcitability anticipates the loss of excitability with the emergence of impairment in LEAD. To test this hypothesis, we compared the behavioral and neurophysiological responses of young and older (ON) normal adults, and LEAD patients during a visuospatial attentional control task. ONs show frontal cortical signal incoherence and posterior cortical hyper-responsiveness with preserved attentional control. LEADs lose the posterior hyper-responsiveness and fail in the attentional task. Our findings suggest that signal incoherence and cortical hyper-responsiveness in aging may contribute to the development of functional impairment in LEAD.

Indexed as

AdolescentAgedAgingAlzheimer DiseaseAttentionBrainCognitive DysfunctionEvoked PotentialsFemaleHumansMaleYoung AdultagingAlzheimer’sERPsexcitabilityvision

Identifiers

PMID32548625
PMCPMC7673476
OpenAlexW3034904829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.